| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 41.33B | 40.82B | 38.34B | 42.80B | 39.36B | 32.46B |
| Gross Profit | 10.93B | 10.81B | 10.08B | 11.63B | 11.44B | 9.09B |
| EBITDA | 2.99B | 2.91B | 2.46B | 3.59B | 4.01B | 2.58B |
| Net Income | 871.00M | 868.00M | -576.00M | 1.39B | 2.04B | 477.71M |
Balance Sheet | ||||||
| Total Assets | 30.75B | 32.98B | 29.66B | 30.49B | 28.83B | 24.77B |
| Cash, Cash Equivalents and Short-Term Investments | 5.30B | 6.50B | 6.03B | 5.21B | 4.82B | 4.09B |
| Total Debt | 2.75B | 3.29B | 3.72B | 2.82B | 3.63B | 4.89B |
| Total Liabilities | 10.04B | 10.94B | 10.91B | 11.44B | 12.53B | 12.33B |
| Stockholders Equity | 20.68B | 22.01B | 18.73B | 19.03B | 16.29B | 12.43B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.25B | 410.00M | 1.42B | 1.94B | 2.44B |
| Operating Cash Flow | 0.00 | 2.27B | 1.28B | 2.56B | 2.94B | 2.94B |
| Investing Cash Flow | 0.00 | -2.42B | -680.00M | -1.55B | -1.10B | -670.20M |
| Financing Cash Flow | 0.00 | 181.00M | -2.00M | -756.34M | -1.60B | -1.68B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
85 Outperform | ¥198.42B | 7.03 | ― | 2.33% | 25.95% | 66.92% | |
78 Outperform | ¥288.85B | 25.26 | ― | 1.17% | 29.51% | 48.81% | |
77 Outperform | ¥20.97B | 14.20 | ― | 3.31% | 0.97% | -10.47% | |
74 Outperform | ¥89.88B | 7.58 | ― | 3.85% | 9.38% | 8.88% | |
73 Outperform | ¥13.34B | 44.98 | ― | 3.84% | 5.57% | 89.21% | |
72 Outperform | ¥254.64B | 13.29 | 7.86% | 2.55% | 0.57% | 4.54% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |